Navigation Links
Suzanne Gagnon, M.D. Joins Idis As Chief Medical Officer

PRINCETON, N.J., March 12, 2013 /PRNewswire/ -- Idis announced today the appointment of Suzanne Gagnon , M.D., as Chief Medical Officer.  Dr. Gagnon takes on responsibility for leading global medical affairs and providing strategic medical and regulatory leadership across all business divisions.  She will also oversee global quality assurance and compliance.

"We are delighted to have Suzanne join us at this exciting time in the global expansion of Idis. Successful managed access programs require alignment among all stakeholders, from R&D though commercial teams to the physicians treating patients," noted Natalie Douglas , CEO of Idis.  "Suzanne brings senior leadership to our team and a unique blend of industry expertise to our customers that will help guide development and implementation of programs that balance stakeholder requirements and effectively address the needs of patients."

The addition of the CMO role and appointment of Dr. Gagnon further strengthens Idis' offering in the US and enhances the Company's ability to deliver patient-centric programs that address the access challenges faced by patients, physicians and companies around the world. 

Dr. Gagnon has more than twenty years leading the medical, regulatory and safety aspects of pharmaceutical product development and has held senior management positions in both academia and in the pharmaceutical and CRO industries.  Formerly CMO and Executive Vice President at ICON Clinical Research for nearly ten years, Dr. Gagnon brings with her senior level experience in medical, regulatory and clinical research operations, as well as safety and risk management expertise.

Dr. Gagnon will be based at Idis' North American headquarters in Princeton, NJ.

About Idis
Idis has 25 years experience of partnering with pharmaceutical and biotechnology companies to create regulatory-compliant, ethical access to medicines for healthcare professionals and their patients with unmet medical needs. Since 1987, Idis has developed and managed access to thousands of medicines from every therapeutic category, impacting the lives of hundreds of thousands of patients in countries around the world. 

Idis leverages decades of experience, regulatory insight, and a thorough understanding of local and global requirements to create access to medicines at every stage of a product's lifecycle from pre-approval to market exit, and in times of unexpected production shortages.

The company's European headquarters are located in Weybridge, United Kingdom, and North American headquarters are located in Princeton, NJ.

For more information about Idis please visit

Contact: Christine Quern
Phone: +1 617 761 6791

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Physician Joins Colorado Center for Reproductive Medicine
2. Sean P. Nolan Joins InterMune as Executive Vice President and Chief Business Officer
3. Founder of Nestle-Acquired Company Joins Prismic Pharmaceuticals
4. Dr. Mickey Urdea Joins Pressure BioSciences Board of Directors
5. Natalie Douglas, CEO of Idis, Joins Global Genes
6. RARE Project Board of Directors
7. Breast Imaging Specialist Dr. Catherine D. Buhler Joins Radiologic Associates of Fredericksburg
8. Stephen Ondra, M.D., Joins Health Care Service Corporation As Enterprise Chief Medical Officer
9. Attorney Ellen Presby Joins The Nemeroff Law Firm In Dallas
10. Kevin Johnson Joins United Allergy Services Board Of Directors
11. Robert Funari Joins NxStage Board of Directors
Post Your Comments:
(Date:6/24/2016)... 2016 Dublin ... addition of the " Global Markets for Spectroscopy ... This report focuses on the ... review, including its applications in various applications. The report ... includes three main industries: pharmaceutical and biotechnology, food and ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June ... -based mobile pulmonary function testing company, is now able to ... devices developed by ndd Medical Technologies , Inc. ... done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ... , can get any needed testing done in the comfort of ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... ... 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop ... The fitness app plans to fix the two major problems leading the fitness industry today:, ... all type program , They don’t eliminate all the reasons people quit their ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due ... up a new, often overlooked aspect of head lice: the parasite’s ability to live away ... a common occurrence, but a necessary one in the event that lice have simply gotten ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
Breaking Medicine News(10 mins):